In breast cancer cells, increased ROS levels in the drug resistant cells caused by retrieving from PI3K inhibitors during drug holidays would cause a proliferative defect in cells, suggesting a positive effect on tumor control [54]. Here, PIK3CA is linked to breast carcinoma.